A detailed history of Neos Investment Management LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Neos Investment Management LLC holds 65,493 shares of ARWR stock, worth $1.29 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
65,493
Previous 60,439 8.36%
Holding current value
$1.29 Million
Previous $1.57 Billion 19.24%
% of portfolio
0.04%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$19.36 - $29.54 $97,845 - $149,295
5,054 Added 8.36%
65,493 $1.27 Billion
Q2 2024

Aug 14, 2024

BUY
$21.87 - $28.24 $565,973 - $730,822
25,879 Added 74.88%
60,439 $1.57 Billion
Q1 2024

May 13, 2024

BUY
$27.21 - $39.48 $621,694 - $902,039
22,848 Added 195.08%
34,560 $988 Million
Q4 2023

Feb 13, 2024

BUY
$21.2 - $31.03 $248,294 - $363,423
11,712 New
11,712 $358 Million

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.08B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Neos Investment Management LLC Portfolio

Follow Neos Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neos Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neos Investment Management LLC with notifications on news.